Zum Hauptinhalt springen

Hepatitiden

26. Januar 2019 | Hepatitiden

Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs.

Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Sweeney S, Ward Z, Platt L, Guinness L, Hickman M, Hope V, Maher L, Iversen J, Hutchinson SJ, Smith J, Ay…

19. Januar 2019 | Hepatitiden

Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up.

Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up. Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferriere V, Pick N, Klein MB; Canadian Co-Infec…

03. Januar 2019 | Hepatitiden

Mechanismus des Leberversagens bei Hepatitis

Mechanismus des Leberversagens bei Hepatitis München – Eine Virushepatitis kann bekanntlich zum Zusammenbruch der Leberfunktion führen. Wissenschaftler der Technischen Universität München (TUM) haben jetzt den Pathomechani…

01. Januar 2019 | Hepatitiden

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. Grottenthaler JM, Werner CR, Steurer M, Spengler U, Berg T, Engelmann C, et al. (2018) PLoS ONE 13(6): e0197544. doi.org/10.1…

01. Januar 2019 | Hepatitiden

Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City. Quinn K, Fong C, Guarino H, Mateu-Gelabert P. Drug Alcohol Depend. 2019 Jan 1;194:453…

01. Januar 2019 | Hepatitiden

Treatment of Hepatitis C: State of the Art 2018.

Treatment of Hepatitis C: State of the Art 2018. Zeuzem S. Dtsch Med Wochenschr. 2018 Dec;143(24):1784-1788. doi: 10.1055/a-0591-5916. Epub 2018 Dec 3. German. [Article in German; Abstract available in German from the publisher] Abstract…

01. Januar 2019 | Hepatitiden

Prevalence of hepatitis C virus infection among key populations in China: a systematic-review.

Prevalence of hepatitis C virus infection among key populations in China: a systematic-review. Liu CR, Li X, Chan PL, Hui Z, Jia JD, Wang XC, Lo YR, Walsh N. Int J Infect Dis. 2018 Dec 4. pii: S1201-9712(18)34584-3. doi: 10.1016/j.ijid.2018.11.006…

Weitere
akutelle Informationen
zu den Themengebieten